Ir al contenido

Obstetricia

Tratamiento de la trombocitopenia

Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy. (abre una nueva ventana)

Decroocq J, Marcellin L, Le Ray C, Willems L.

Fuente‎: Obstet Gynecol 2014;124(2 Pt 2 Suppl 1):481-3.

Indexado en‎: PubMed 25004319

DOI‎: 10.1097/AOG.0000000000000371

https://www.ncbi.nlm.nih.gov/pubmed/25004319 (abre una nueva ventana)

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study. (abre una nueva ventana)

Michel M, Ruggeri M, Gonzalez-Lopez TJ, Alkindi SS, Cheze S, Ghanima W, Tvedt THA, Ebbo M, Terriou L, Bussel JB, Godeau B

Fuente‎: Blood 2020;136(26):3056-61.

Indexado en‎: PubMed 32814348

DOI‎: 10.1182/blood.2020007594

https://www.ncbi.nlm.nih.gov/pubmed/32814348 (abre una nueva ventana)

A case of refractory immune thrombocytopenia in pregnancy managed with elthrombopag. (abre una nueva ventana)

Purushothaman J, Puthumana KJ, Kumar A, Innah SJ, Gilvaz S.

Fuente‎: Asian J Transfus Sci 2016;10(2):155-8.

Indexado en‎: PubMed 27605856

DOI‎: 10.4103/0973-6247.177204

https://www.ncbi.nlm.nih.gov/pubmed/27605856 (abre una nueva ventana)

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. (abre una nueva ventana)

Saleh MN, Bussel JB, Cheng G, Meyer O, Bailey CK, Arning M, Brainsky A; EXTEND Study Group.

Fuente‎: Blood 2013;121(3):537-45.

Indexado en‎: PubMed 23169778

https://www.ncbi.nlm.nih.gov/pubmed/23169778 (abre una nueva ventana)